STOCK TITAN

Nascent Biotech (NBIO) Net Income by Year

NBIO

Nascent Biotech reported a net loss of $2.1M in fiscal year 2024. The table below carries 11 fiscal years, from 2014 to 2024, and the quarters Nascent Biotech has filed alongside them.

FY2024 annual
Net Income -$2.1M
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2025, ended Jun 30, 2024 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

NBIO Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-K
Net Income-$2.1MN/A-$470K+50.9%-$959KN/AN/AN/A$1.1M+127.4%-$4.1M-92.8%-$2.2MN/A

NBIO Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-QQ2'2210-Q
Net Income-$377KN/A-$205K+75.5%-$829K-469.2%N/AN/A-$837K-240.2%-$146K+31.0%N/AN/A$597K-$211K+49.5%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Nascent Biotech financials

Frequently Asked Questions

What was Nascent Biotech's net income in fiscal year 2024?

Nascent Biotech reported a net loss of $2.1M in fiscal year 2024.

What was Nascent Biotech's net income in the most recent quarter?

Nascent Biotech (NBIO) reported -$377K in net income in Q1 2025.

What does net income mean on a financial statement?

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Nascent Biotech (NBIO) reported on that line in every period on record.